Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea

Olubukola T Idoko; Kinga K Smolen; Oghenebrume Wariri; Abdulazeez Imam; Casey P Shannon; Tida Dibassey; Joann Diray-Arce; Alansana Darboe; Julia Strandmark; Rym Ben-Othman; Oludare A Odumade; Kerry McEnaney; Nelly Amenyogbe; William S Pomat; Simon van Haren; Guzmán Sanchez-Schmitz; Ryan R Brinkman; Hanno Steen; Robert E W Hancock; Scott J Tebbutt; Peter C Richmond; Anita H J van den Biggelaar; Tobias R Kollmann; Ofer Levy; Al Ozonoff; Beate Kampmann

doi:10.3389/fped.2020.610461

Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea

Front Pediatr. 2020 Nov 17:8:610461. doi: 10.3389/fped.2020.610461. eCollection 2020.

Authors

Olubukola T Idoko^{1

2

3

4}, Kinga K Smolen^{2

5}, Oghenebrume Wariri¹, Abdulazeez Imam¹, Casey P Shannon⁶, Tida Dibassey¹, Joann Diray-Arce^{2

5}, Alansana Darboe¹, Julia Strandmark¹, Rym Ben-Othman⁷, Oludare A Odumade^{2

4

8}, Kerry McEnaney^{2

9}, Nelly Amenyogbe¹⁰, William S Pomat¹¹, Simon van Haren^{2

5}, Guzmán Sanchez-Schmitz^{2

5}, Ryan R Brinkman^{12

13}, Hanno Steen^{2

5

14}, Robert E W Hancock¹⁵, Scott J Tebbutt^{6

16

17}, Peter C Richmond^{10

18}, Anita H J van den Biggelaar¹⁰, Tobias R Kollmann¹⁰, Ofer Levy^{2

5

19}, Al Ozonoff^{2

5}, Beate Kampmann^{1

4}

Affiliations

¹ Vaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, Gambia.
² Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.
³ CIH LMU Center for International Health, Medical Center of the University of Munich (LMU), Munich, Germany.
⁴ The Vaccine Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom.
⁵ Harvard Medical School, Boston, MA, United States.
⁶ PROOF Centre of Excellence, Vancouver, BC, Canada.
⁷ Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
⁸ Division of Medicine Critical Care, Harvard Medical School, Boston Children's Hospital, Boston, MA, United States.
⁹ Department of Cardiology, Boston Children's Hospital, Boston, MA, United States.
¹⁰ Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.
¹¹ Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
¹² BC Cancer Agency, Vancouver, BC, Canada.
¹³ Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
¹⁴ Department of Pathology, Boston Children's Hospital, Boston, MA, United States.
¹⁵ Department of Microbiology & Immunology, University of British Columbia, Vancouver, BC, Canada.
¹⁶ Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.
¹⁷ Division of Respiratory Medicine, Department of Medicine, UBC, Vancouver, BC, Canada.
¹⁸ Division of Pediatrics, School of Medicine, Perth Children's Hospital, University of Western Australia, Nedlands, WA, Australia.
¹⁹ Broad Institute of MIT & Harvard, Cambridge, MA, United States.

Abstract

[This corrects the article DOI: 10.3389/fped.2020.00197.].

Keywords: OMICS; immunogenicity; markers; newborn; systems biology; vaccine.

Copyright © 2020 Idoko, Smolen, Wariri, Imam, Shannon, Dibassey, Diray-Arce, Darboe, Strandmark, Ben-Othman, Odumade, McEnaney, Amenyogbe, Pomat, van Haren, Sanchez-Schmitz, Brinkman, Steen, Hancock, Tebbutt, Richmond, van den Biggelaar, Kollmann, Levy, Ozonoff and Kampmann.

Publication types

Published Erratum